UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB

                QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934


                       FOR THE PERIOD ENDED: March 31, 2002
                        COMMISSION FILE NUMBER: 333-06718

                                  VIROPRO INC.
             ------------------------------------------------------
             (Exact name of registrant as specified in its charter)


            NEVADA                                            13-3124057
-------------------------------                         --------------------
(State or other jurisdiction of                         (IRS Employer
incorporation or organization)                           Identification No.)

              3163 Kennedy Boulevard, Jersey City, New Jersey 07306
          ------------------------------------------------------------
          (Address, including zip code, of principal executive offices)

                                 (201) 217-4137
               ---------------------------------------------------
              (Registrant's telephone number, including area code)

                                      N/A
    ------------------------------------------------------------------------
(Former name, former address & former fiscal year, if changed since last report)

Indicate by check  mark whether the  registrant (1) has filed all  documents and
reports required to be filed by Sections 13 or 15(d) of  the Securities Exchange
Act of 1934 during the preceding  12 months (or for such shorter period that the
registrant was required to  file such reports), and (2) has been subject to such
filings for the past 90 days.

YES  ( )    NO  (X)

                      APPLICABLE ONLY TO CORPORATE ISSUERS:

As of  March 31, 2002, the number of the  Company's shares  of par  value  $.001
common stock outstanding was 7,324,749.














<PAGE>
                                  VIROPRO, INC.
                                   FORM 10-QSB
                                  MARCH 31, 2002


                                      INDEX


Part I - FINANCIAL INFORMATION

Item 1 - Financial Statements

Condensed Consolidated Balance Sheet..........................................4

Consolidated Statements of Operation..........................................5

Consolidated Statements of Cash Flow..........................................7

Notes to Financial Statements.................................................8

Item 2 - Management's Discussion and Analysis of Financial Condition and
            Results of Operations............................................12

PART II - OTHER INFORMATION..................................................14



SIGNATURES...................................................................14


































<PAGE>
                                  VIROPRO, INC.
                                   FORM 10-QSB
                                  MARCH 31, 2002

Part I - FINANCIAL INFORMATION








                               VIROPRO, INC.

                            FINANCIAL STATEMENTS

                         MARCH  31, 2002 AND 2001
















                               VIROPRO, INC.


                             TABLE OF CONTENTS


                                                                   PAGE


FINANCIAL STATEMENTS

   BALANCE SHEET                                                      2
   STATEMENTS OF OPERATIONS                                         3-4
   STATEMENTS OF CASH FLOWS                                           5
   NOTES TO  FINANCIAL STATEMENTS                                   6-9













<PAGE>
                                 VIROPRO, INC.
                                 BALANCE SHEET
                      MARCH 31, 2002 AND JUNE 30, 2001


                                             MARCH 31,       JUNE 30,
                                               2002            2001
                                           (Unaudited)
                                          --------------  --------------

                                    ASSETS

Current Assets
   Cash                                   $        - 0 -  $        - 0 -
                                          --------------  --------------
   Total  Current  Assets                          - 0 -           - 0 -

      Total Assets                        $        - 0 -  $        - 0 -
                                          ==============  ==============

                LIABILITIES & SHAREHOLDERS' EQUITY (DEFICIENCY)

Current Liabilities
   Accounts payable and accrued expenses  $     434,551   $     390,811
   Notes payable                                583,200         583,200
                                          --------------  --------------
      Total Current Liabilities               1,017,751         974,011
                                          --------------  --------------
      Total Liabilities                       1,017,751         974,011
                                          --------------  --------------

Shareholders' Equity
   Common stock - $.001 par value;
     authorized 50,000,000; issued and
     outstanding 7,474,749 shares                 7,475           7,475
   Additional Paid-In-Capital                 1,102,584       1,102,584
   Accumulated Deficit                       (2,127,810)     (2,084,070)
                                          --------------  --------------
Total Shareholders' Equity (Deficiency)      (1,017,751)      (974,011)

Total Liabilities & Shareholders'
  Equity (Deficiency)                     $        - 0 -  $        - 0 -
                                          ==============  ==============


















See accompanying notes to financial statements.
<PAGE>
                                  VIROPRO, INC.
                           STATEMENTS OF OPERATIONS
              FOR THE THREE MONTHS  ENDED MARCH 31 2002 AND 2001


                                                   2002           2001
                                              --------------  --------------
Sales (net)                                   $        - 0 -  $        - 0 -
Cost of sales                                          - 0 -           - 0 -
                                              --------------  --------------
Gross profit                                           - 0 -           - 0 -
                                              --------------  --------------

Operating Expenses:
   Selling, general and administrative                 - 0 -           - 0 -
                                              --------------  --------------
Income (loss) before interest and
   other expense                                       - 0 -           - 0 -
                                              --------------  --------------

Interest and other expenses
   Interest expense                                 (14,580)        (14,580)
                                              --------------  --------------
     Total interest and other expenses              (14,580)        (14,580)
                                              --------------  --------------

Net Loss before provision for income taxes          (14,580)        (14,580)
Provision for income taxes                             - 0 -           - 0 -
                                              --------------  --------------
Net loss                                      $     (14,580)  $     (14,580)
                                              ==============  ==============

Income (loss) per common share                $       (.002)  $       (.002)
                                              ==============  ==============

Weighted average common shares outstanding        7,474,749       7,474,749
                                              ==============  ==============
























See accompanying notes to financial statements.
<PAGE>
                                 VIROPRO, INC.
                           STATEMENTS OF OPERATIONS
               FOR THE NINE MONTHS ENDED MARCH 31, 2002 AND 2001


                                                   2002           2001
                                              --------------  --------------
Sales (net)                                   $        - 0 -  $        - 0 -
Cost of sales                                          - 0 -           - 0 -
                                              --------------  --------------
Gross profit                                           - 0 -           - 0 -
                                              --------------  --------------

Operating Expenses:
   Selling, general and administrative                 - 0 -           - 0 -
                                              --------------  --------------
Income (loss) before interest and
   other expense                                       - 0 -           - 0 -
                                              --------------  --------------

Interest and other expenses
   Interest expense                                 (43,740)        (43,740)
                                              --------------  --------------
     Total interest and other expenses              (43,740)        (43,740)
                                              --------------  --------------
Net Loss before provision for income taxes          (43,740)        (43,740)

Provision for income taxes                             - 0 -           - 0 -
                                              --------------  --------------

Net loss                                      $     (43,740)  $     (43,740)
                                              ==============  ==============



Income (loss) per common share                $       (.006)  $       (.006)
                                              ==============  ==============

Weighted average common shares outstanding        7,474,749       7,474,749
                                              ==============  ==============





















                See accompanying notes to financial statements.
<PAGE>
                                VIROPRO, INC.
                           STATEMENTS OF CASH FLOWS
              FOR THE NINE  MONTHS  ENDED MARCH 31, 2002 AND 2001


                                                   2002           2001
                                              --------------  --------------
Cash Flows From Operations:
  Net Loss                                    $     (43,740)  $     (43,740)
  Adjustments to Reconcile Net Income To Net
   Cash Used for Operating Activities:
     Changes in Assets and Liabilities:
       Increase (Decrease) in Accounts
         Payable and Accrued Expenses                43,740          43,740
                                              --------------  --------------
      Net Cash Used in Operations                      - 0 -           - 0 -
                                              --------------  --------------

Net Increase (Decrease) in Cash                        - 0 -           - 0 -
Cash  - Beginning of Period                            - 0 -           - 0 -
                                              --------------  --------------
Cash  - End of Period                         $        - 0 -  $        - 0 -
                                              ==============  ==============

Supplemental Cash Flow Information:
   Interest Expense Paid                      $        - 0 -  $        - 0 -
   Interest Taxes Paid                        $        - 0 -  $        - 0 -


































See accompanying notes to financial statements.
<PAGE>
                                  VIROPRO, INC.
                         NOTES TO FINANCIAL STATEMENTS
                             MARCH 31, 2002 AND 2001

NOTE 1 - BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

     A.  BUSINESS DESCRIPTION AND ACTIVITY

         Viropro, Inc. (fka Food Concepts, Inc.) was organized under  the  laws
         of  the  State  of  Nevada  on June 16, 1982.  On October 27, 1995 the
         Company reorganized and acquired  Savon Coffee, Inc. as a wholly owned
         subsidiary.   On  January 1, 1996, the  Company  acquired  Palm  Beach
         Gourmet Coffee, Inc.  as a wholly owned subsidiary.  On March 31, 1998
         the Company divested itself  of  its  coffee  operations.  It acquired
         Insecta  Sales and Research, Inc. as a wholly owned  subsidiary.   The
         principal  business  of  the  Company is the wholesale distribution of
         various insecticides.

     B.  SIGNIFICANT ACCOUNTING POLICIES

         The financial information contained  herein  is unaudited but includes
         all  normal  and  recurring  adjustments  which  in   the  opinion  of
         management are necessary to present fairly the information  set forth.
         The  Company's  results  for  the  interim periods are not necessarily
         indicative of the results to be expected  for  the  fiscal year ending
         June   30,  2002.  These  financial  statements  should  be  read   in
         conjunction   with   the  audited  financial  statements  and  related
         footnotes for the year  ended  June 30, 2001 included in the Company's
         annual report on Form 10-KSB.

         CASH AND CASH EQUIVALENTS
         For purposes of the statement of  cash  flows,  the  Company considers
         cash  and  highly  liquid securities (consisting primarily  of  money-
         market investments)  with  an original maturity or redemptions options
         of three months or less to be cash and equivalents.

         During 2001  the Company maintained  no  cash  and  equivalents with a
         bank.   Bank  deposits  are  insured by the FDIC up to $100,000.   The
         Company may, from time to time,  maintain  balances in excess of these
         insured limits.

         CONCENTRATION OF CREDIT RISK
         Financial instruments that potentially subject  the  Company to credit
         risk  consist  principally  of  trade receivables.  Trade  receivables
         terms  are  generally  30 days.  The  Company  performs  services  and
         extends credit based on  an  evaluation  of  the  customers' financial
         condition  without  requiring  collateral.   Exposure  to   losses  on
         receivables  is  expected  to  vary  by  customer due to the financial
         condition of each customer.  The Company monitors  exposure  to credit
         losses  and  maintains  allowances  for  anticipated losses considered
         necessary under the circumstances.

         PROPERTY AND EQUIPMENT
         Property and equipment is recorded at cost.   Expenditures  for  major
         betterments  and  additions  are  charged  to the asset accounts while
         replacements, maintenance and repairs which  do  not improve or extend
         the lives of the respective assets are charged to expense currently.





<PAGE>
                                VIROPRO, INC.
                         NOTES TO FINANCIAL STATEMENTS
                            MARCH 31, 2002 AND 2001

NOTE 1 - BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

         DEPRECIATION
         Depreciation  of  property  and  equipment  is  determined   utilizing
         straight-line and accelerated methods at various rates based generally
         on  the  estimated useful lives of the assets.  The range of estimated
         useful lives is as follows:

              Office furniture and equipment               5 to 7 years
              Machinery and equipment                      5 to 7 years

         INVENTORIES
         Inventories  are  stated  at  the  lower  of cost (first-in, first-out
         method) or market (replacement cost).  The Company had no inventory in
         2001 and 2002.

         USE OF ESTIMATES
         The preparation of financial statements in  conformity  with generally
         accepted  accounting principles requires management to make  estimates
         and assumptions  that  affect  the  reported  amounts  of  assets  and
         liabilities and disclosure of contingent assets and liabilities at the
         date  of the financial statements and the reported amounts of revenues
         and expenses during the reporting period.  Actual results could differ
         from those estimates.

         The Company  has  recorded  a  deferred  tax asset which is completely
         offset  by a valuation allowance.  Realization  of  the  deferred  tax
         asset is  dependent  on  generating  sufficient  taxable income in the
         future.   The  amount of the deferred tax asset considered  realizable
         could change in  the  near  term if estimates of future taxable income
         are modified.

         INCOME TAXES
         The  Company accounts for income  taxes  under  the  liability  method
         according  to  Statement  of  Financial  Accounting Standards No. 109.
         Deferred  tax  assets and liabilities are recognized  for  future  tax
         consequences  attributable   to   differences  between  the  financial
         statements carrying amounts of existing  assets  and  liabilities  and
         their  respective  tax  base.  Deferred tax assets and liabilities are
         measured using enacted tax  rates  expected to apply to taxable income
         in the years in which those temporary  differences  are expected to be
         recovered or settled.

         REVENUE RECOGNITION
         Revenue from product sales is recognized by the Company when title and
         risk  of loss passes to the distributor, which generally  occurs  upon
         shipment  from  the  manufacturing  facilities  or third party storage
         facilities.

         ADVERTISING
         Advertising  is  expensed  as  incurred  and is included  in  selling,
         general and administrative expenses.






<PAGE>
                                  VIROPRO, INC.
                         NOTES TO FINANCIAL STATEMENTS
                            MARCH 31, 2002 AND 2001

NOTE 1 - BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)


         NET LOSS PER SHARE
         The Company applies Statement of Financial  Accounting  Standards  No.
         128, "Earnings Per Share" (FAS 128).  Net losses per share is computed
         by  dividing net loss  by the weighted average number of common shares
         outstanding   during   the   reported   periods.    Outstanding  stock
         equivalents  were  not considered in the calculation as  their  effort
         would have been anti-dilutive.

         SEGMENT REPORTING
         During 1998, the Company  adopted Financial Accounting Standards Board
         ("FASB")  statement  No.  131,   "Disclosure   about  Segments  of  an
         Enterprise and Related Information".  The Company  has  considered its
         operations  and has determined that it operates in a single  operating
         segment  for  purposes   of   presenting   financial  information  and
         evaluating   performance.    As   such,  the  accompanying   financial
         statements present information in a format that is consistent with the
         financial information used by management for internal use.

         FAIR VALUE OF FINANCIAL INSTRUMENTS
         The carrying values of cash and equivalents,  accounts  receivable and
         notes  receivable  approximate  their  fair  values  due to the  short
         maturity of these instruments.

         The  fair value of the notes payable is determined by calculating  the
         present  value  of  the  note  by a current market rate of interest as
         compared to the stated rate of interest.   The difference between fair
         value and the carrying values is not deemed to be significant.

         COMPREHENSIVE INCOME
         The  items affecting comprehensive income are  not  materials  to  the
         financial statements and, accordingly, are not presented herein.

NOTE 2 - GOING CONCERN

         The accompanying financial statements have been prepared in conformity
         with  generally  accepted  accounting  principles,  which  contemplate
         continuation  of  the  Company  as  a  going concern.  The Company has
         sustained substantial operating losses and  negative  cash  flows from
         operations  since  inception.   In the absence of achieving profitable
         operations  and  positive  cash flows  from  operations  or  obtaining
         additional debt or equity financing,  the  Company may have difficulty
         meeting current obligations.

         In  view  of these matters continued operations  of  the  Company  are
         dependent upon the Company's ability to meet its financial obligations
         and to enter  into  a  profitable enterprise..  Management is pursuing
         opportunities for  the Company to continue as a going concern.








<PAGE>
                                  VIROPRO, INC.
                         NOTES TO FINANCIAL STATEMENTS
                              MARCH 31, 2002 AND 2001

NOTE 3 - RELATED PARTY TRANSACTIONS

         Between September 1997 through  June  1999, the Company borrowed funds
         under notes payable aggregating $583,200  from  Jade  Investments,  as
         major  shareholder  controlled entity, with interest at 10%. The notes
         are payable on demand.   Interest  of  $224,426  has been  accrued  at
         March  31, 2002.  No payments have been made.

NOTE 4 - INCOME TAXES

         The  Company  had  deferred  tax  assets  of  approximately   $610,000
         principally  comprised  of net  operating losses.   The  deferred  tax
         assets were offset  by  a  valuation  allowance  in  the  same amount.
         Deferred  tax assets, net of a valuation allowance, are recorded  when
         management  believes it is more likely than not that tax benefits will
         be realized.

         The   Company  has   net   operating   loss   carry-forwards  totaling
         approximately $2,084,000, expiring in 2016.







































<PAGE>
                                  VIROPRO, INC.
                                   FORM 10-QSB
                                  MARCH 31, 2002

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
        AND RESULTS OF OPERATIONS.

RESULTS  OF  OPERATIONS

NINE  MONTHS  ENDED  MARCH  31,  2002  AND  2001

During  the nine month periods ending  March 31, 2002  and  2001,  the  Company
incurred  a loss of  $43,740.  Gross profit for the nine  month  periods  ended
March 31,  2002 and 2001 was zero dollars.  The Company incurred  no  operating
expenses during either period.

REVENUES

During  the  nine month  periods ended  March 31,  2002 and 2000, the Company's
revenues were zero dollars.   Revenues were previously derived from the sale of
the  insecticide  products sold under  the  Insecta Brand name.  Revenues  were
recognized when the product  sold  was shipped  to the Company's customer.  The
absence of revenue from year to year is due to the Company ceasing its business
operations  due  to  the EPA  changing  the applicable regulations covering the
sale  and  distribution  of products  containing  the active ingredient  in the
Company's Insecta brand insecticide.  As  previously  reported the Company  was
notified  that effective December 2001 the active ingredient of its insecticide
formulation could no longer be sold.

OPERATING  EXPENSES

During the nine months ended March 31, 2002 and 2001 the Company  incurred  no
operating expenses.  This reflects  the  above-mentioned cessation of business
due  to  changes in  EPA regulations.

MATERIAL CHANGES IN FINANCIAL CONDITION, LONGEVITY AND CAPITAL RESOURCES.

At  March  31, 2002, the Company had $0 in cash and cash  equivalents, the same
as at the start  of the fiscal year, June 30, 2001.

THREE MONTHS  ENDED  MARCH  31,  2002  AND  2001

During  the three  month periods  ending March  31, 2002 and 2001, the  Company
incurred a loss of  $14,580.  Gross profit  for the  three month periods  ended
March 31,  2002 and 2001  was zero dollars.  The Company incurred no  operating
expenses during the period.
















<PAGE>
                                  VIROPRO, INC.
                                   FORM 10-QSB
                                  MARCH 31, 2002


REVENUES

During  the three month  periods ended  March 31, 2002 and 2001,  the Company's
revenues were zero dollars. Revenues were previously  derived from  the sale of
the  insecticide  products sold under  the  Insecta  Brand name.  Revenues were
recognized when the product  sold  was shipped  to the Company's customer.  The
absence of revenue from year to year is due to the Company ceasing its business
operations  due  to  the EPA  changing the  applicable regulations covering the
sale  and  distribution  of products containing  the active  ingredient  in the
Company's Insecta brand insecticide.  As previously  reported the  Company  was
notified that  effective December 2001 the active ingredient of its insecticide
formulation could no longer be sold.

OPERATING  EXPENSES

During the three months ended March 31, 2002 and 2001 the  Company incurred  no
operating expenses.  This reflects  the  above-mentioned  cessation of business
due  to  changes in  EPA regulations.

MATERIAL CHANGES IN FINANCIAL CONDITION, LONGEVITY AND CAPITAL RESOURCES.

At  March  31, 2002, the Company had $0 in cash and cash  equivalents, the same
as at the start  of the fiscal year, June 30, 2001.

































<PAGE>
                                  VIROPRO, INC.
                                   FORM 10-QSB
                                  MARCH 31, 2002


PART  II

OTHER  INFORMATION

Item  1.  Legal  Proceedings.

NONE

Item  2.  Changes  in  Securities.

NONE

Item 3.  Defaults  Upon  Senior  Securities.

None.

Item  4.  Submission  of  Matters  to  a  Vote  of  Security-Holders.

None

Item  5.  Other  Information.

NONE


Item  6.  Exhibits  and  Reports  on  Form  8-K.

(a)      Omitted exhibits not required.

(b)      Reports  on  Form  8-K

No reports on Form 8-K were filed in the period ending March 31, 2002.



                                    SIGNATURE

In  accordance  with  the requirements of the Security Exchange Act of 1934, the
Registrant has caused this report to be signed on its behalf by the undersigned,
duly  authorized.


VIROPRO, INC.



Date: September 09, 2002                 By: /s/ Hugh Johnson
                                         --------------------------------
                                         Hugh Johnson, President